Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Clinical Research Standardized Reading Procedures iRECIST RECIST Research with mint mintLesion

Related Resources

Related Resources

Woman reading the article on multiparametric MRI in prostate cancer treatments on her laptop

Use of Multiparametric MRI in Prostate Cancer Treatments: A Prospective Study

The prospective study conducted by LMU Klinikum München investigates the effectiveness of vascular-targeted photodynamic therapy (VTP) and…

Image showing MR image analysis using the dedicated semiautomatic software tool mint Lesion™

LMU Klinikum Munich: Monitoring Prostate Cancer Treatments with VTP and HIFU - The Use of Multiparametric MRI

The prospective study conducted by LMU Klinikum Munich investigates the treatment of localized prostate cancer using two techniques: vascular-targeted…

RACOON FADEN: Pioneering Early Detection of Adenomyosis – Insights from Prof. Mechsner (Charité Berlin) and Prof. May (University Hospital Erlangen)

Adenomyosis is a gynecological condition of the uterus and a form of endometriosis. Approximately 10 percent of women of reproductive age are affected…